A polymorphism in the angiotensin II type 1 receptor gene has different effects on the risk of diabetic nephropathy in men and women.

[1]  H. Hillege,et al.  Cardiovascular Risk Associated with Interactions among Polymorphisms in Genes from the Renin-Angiotensin, Bradykinin, and Fibrinolytic Systems , 2010, PloS one.

[2]  A. Johnson,et al.  Protective actions of estrogen on angiotensin II-induced hypertension: role of central nitric oxide. , 2009, American journal of physiology. Heart and circulatory physiology.

[3]  Jiunn-lee Lin,et al.  A propensity score-based case-control study of renin-angiotensin system gene polymorphisms and diastolic heart failure. , 2009, Atherosclerosis.

[4]  I. Kockum,et al.  The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk. , 2008, Journal of diabetes and its complications.

[5]  P. Ridker,et al.  Association of renin–angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study , 2008, Journal of hypertension.

[6]  Kari E North,et al.  Angiotensin II type 1 receptor polymorphisms and susceptibility to hypertension: A HuGE review , 2008, Genetics in Medicine.

[7]  B. Stegmayr,et al.  Genetic polymorphisms in the renin–angiotensin system confer increased risk of stroke independently of blood pressure: a nested case–control study , 2008, Journal of hypertension.

[8]  M. Farrall,et al.  European rational approach for the genetics of diabetic complications--EURAGEDIC: patient populations and strategy. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[9]  J. Xue,et al.  Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause? , 2005, Kidney international.

[10]  M. Koulu,et al.  Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients. , 2004, Diabetes care.

[11]  B. Brenner,et al.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.

[12]  J F Reckelhoff,et al.  Gender Differences in the Regulation of Blood Pressure , 2001, Hypertension.

[13]  S. Seliger,et al.  Gender and the progression of renal disease , 2001, Current opinion in nephrology and hypertension.

[14]  H. Parving,et al.  Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients , 2000, Diabetologia.

[15]  G. Dahlquist,et al.  Familial and perinatal risk factors for micro- and macroalbuminuria in young IDDM patients. , 1998, Diabetes.

[16]  J. Tuomilehto,et al.  Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland , 1998, Diabetologia.

[17]  A. Krolewski,et al.  Synergistic effect of angiotensin II type 1 receptor genotype and poor glycaemic control on risk of nephropathy in IDDM , 1997, Diabetologia.

[18]  D. Dunger,et al.  Lack of association of angiotensin II type 1 receptor gene polymorphism with diabetic nephropathy in insulin‐dependent diabetes mellitus , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[19]  G Chatellier,et al.  Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes: Genetique de la Nephropathie Diabetique (GENEDIAB) study group. , 1997, The Journal of clinical investigation.

[20]  K Borch-Johnsen,et al.  Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study , 1996, BMJ.

[21]  A. Krolewski,et al.  DdeI polymorphism in the AGTR1 gene. , 1994, Human molecular genetics.

[22]  H. Parving,et al.  Is diabetic nephropathy an inherited complication? , 1992, Kidney international.

[23]  B. Persson,et al.  Enalapril reduces microalbuminuria in young normotensive Type 1 (insulin-dependent) diabetic patients irrespective of its hypotensive effect , 1990, Diabetologia.

[24]  E. Seaquist,et al.  Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy. , 1989, The New England journal of medicine.

[25]  H. Keen,et al.  Raised arterial pressure in parents of proteinuric insulin dependent diabetics. , 1987, British medical journal.

[26]  S. Kreiner,et al.  Declining Incidence of Persistent Proteinuria in Type I (Insulin-Dependent) Diabetic Patients in Denmark , 1987, Diabetes.

[27]  J. Laragh,et al.  Renin relationship to sex, race and age in a normotensive population. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[28]  C. Mogensen,et al.  Predicting diabetic nephropathy in insulin-dependent patients. , 1984, The New England journal of medicine.

[29]  J. Reckelhoff,et al.  Sexual dimorphism in the blood pressure response to angiotensin II in mice after angiotensin-converting enzyme blockade. , 2010, American journal of hypertension.

[30]  Pak Chung Sham,et al.  Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits , 2003, Bioinform..